Rivaroxaban and recurrent stroke prevention in AF

Philip B. Gorelick

doi:10.1016/S1474-4422(12)70044-3

Rivaroxaban and recurrent stroke prevention in AF

Philip B. Gorelick^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	295-297
Number of pages	3
Journal	The Lancet Neurology
Volume	11
Issue number	4
DOIs	https://doi.org/10.1016/S1474-4422(12)70044-3
State	Published - Apr 2012

ASJC Scopus subject areas

Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1474-4422(12)70044-3

Cite this

@article{33edb160c6844fd3a89a995c6e7a5d87,

title = "Rivaroxaban and recurrent stroke prevention in AF",

author = "Gorelick, {Philip B.}",

year = "2012",

month = apr,

doi = "10.1016/S1474-4422(12)70044-3",

language = "English (US)",

volume = "11",

pages = "295--297",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - Rivaroxaban and recurrent stroke prevention in AF

AU - Gorelick, Philip B.

PY - 2012/4

Y1 - 2012/4

UR - http://www.scopus.com/inward/record.url?scp=84858621615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858621615&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(12)70044-3

DO - 10.1016/S1474-4422(12)70044-3

M3 - Letter

C2 - 22402055

AN - SCOPUS:84858621615

SN - 1474-4422

VL - 11

SP - 295

EP - 297

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 4

ER -

Rivaroxaban and recurrent stroke prevention in AF

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this